Full Text View
Tabular View
No Study Results Posted
Related Studies
Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children: Hydroxycarbamide Effect on Isolated Hypoxemia (SOMMEDREP)
This study is not yet open for participant recruitment.
Verified March 2012 by Assistance Publique - Hôpitaux de Paris
Study NCT01565954   Information provided by Assistance Publique - Hôpitaux de Paris

First Received on March 27, 2012.   Last Updated on April 10, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sickle Cell Disease
Respiration Disorders
Additional conditions recognized in this trial
Anemia, Sickle Cell
Respiratory Tract Diseases
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Interventions listed in this trial
Hydroxycarbamide
Additional drug interventions recognized in this trial
Hydroxyurea
More general drug interventions related to this trial
Antineoplastic Agents
Antisickling Agents
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services